v3.25.3
CONDENSED BALANCE SHEETS (Unaudited) - USD ($)
Sep. 30, 2025
Mar. 31, 2025
Current Assets    
Cash $ 444,818 $ 64,357
Other receivable 3,062
Advance – related party 145,000
Prepaid expenses 50,000
Total Current Assets 589,818 117,419
Deferred offering costs 131,563
Investments held in Trust Account 83,302,976
Total Assets 83,892,794 248,982
Current Liabilities    
Accrued expenses 50,160 40,000
Promissory note – related party 200,000
Total Current Liabilities 50,160 240,000
Deferred underwriting fee payable 3,312,000
Total Liabilities 3,362,160 240,000
Commitments and Contingencies – see Note 6    
Ordinary shares subject to possible redemption, 8,280,000 shares and 0 shares at redemption value of $10.06 and $0 per share as of September 30, 2025 and March 31, 2025, respectively 83,302,976
Shareholders’ (Deficit) Equity    
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 3,126,650 shares and 2,898,000 shares issued and outstanding as of September 30, 2025 and March 31, 2025, respectively (excluding 8,280,000 shares subject to possible redemption) [1] 313 290
Additional paid-in capital 24,710
Accumulated deficit (2,772,655) (16,018)
Total Shareholders’ (Deficit) Equity (2,772,342) 8,982
Total Liabilities, Shares Subject to Possible Redemption and Shareholders’ (Deficit) Equity $ 83,892,794 $ 248,982
[1] Ordinary shares have been retroactively restated to reflect the first amendment to the Subscription Agreement, which allowed the Sponsor to increase the purchase of ordinary shares from 2,415,000 to 2,898,000 shares for $25,000, including an aggregate of up to 378,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).